Mitochondrial pyruvate carrier function determines cell stemness and metabolic reprogramming in cancer cellsXiaoli Li, Zhenhe Suo, Mingzhi Zhang et al.|Oncotarget|2017Cited by 69
MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancerXiaoli Li, Zhenhe Suo, Yasai Ji et al.|BMC Cancer|2016Cited by 48
High SRPX2 protein expression predicts unfavorable clinical outcome in patients with prostate cancerMeng Zhang, Zhenhe Suo, Xiaoli Li et al.|OncoTargets and Therapy|2018Cited by 14
MtDNA depletion influences the transition of CD44 subtypes in human prostate cancer DU145 cellsXiaoran Li, Zhenhe Suo, Mantas Grigalavicius et al.|Tumor Biology|2017Cited by 1